Advanced search
1 file | 817.50 KB Add to list

Boosting care and knowledge about hereditary cancer : European Reference Network on Genetic Tumour Risk Syndromes

(2019) FAMILIAL CANCER. 18(2). p.281-284
Author
Organization
Abstract
Approximately 27-36million patients in Europe have one of the similar to 5.000-8.000 known rare diseases. These patients often do not receive the care they need or they have a substantial delay from diagnosis to treatment. In March 2017, twenty-four European Reference Networks (ERNs) were launched with the aim to improve the care for these patients through cross border healthcare, in a way that the medical knowledge and expertise travels across the borders, rather than the patients. It is expected that through the ERNs, European patients with a rare disease get access to expert care more often and more quickly, and that research and guideline development will be accelerated resulting in improved diagnostics and therapies. The ERN on Genetic Tumour Risk Syndromes (ERN GENTURIS) aims to improve the identification, genetic diagnostics, prevention of cancer, and treatment of European patients with a genetic predisposition for cancer. The ERN GENTURIS focuses on syndromes such as hereditary breast cancer, hereditary colorectal cancer and polyposis, neurofibromatosis and more rare syndromes e.g. PTEN Hamartoma Tumour Syndrome, Li Fraumeni Syndrome and hereditary diffuse gastric cancer.
Keywords
Hereditary cancer, Cross border health care, European Reference Network, Rare diseases, Syndrome, Genetic, COLORECTAL-CANCER, PREVENTION, GUIDELINES

Downloads

  • Vos2018 Article BoostingCareAndKnowledgeAboutH.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 817.50 KB

Citation

Please use this url to cite or link to this publication:

MLA
Vos, Janet R et al. “Boosting Care and Knowledge About Hereditary Cancer : European Reference Network on Genetic Tumour Risk Syndromes.” FAMILIAL CANCER 18.2 (2019): 281–284. Print.
APA
Vos, J. R., Giepmans, L., Röhl, C., Geverink, N., Hoogerbrugge, N., ERN Genturis, on behalf of, Poppe, B., et al. (2019). Boosting care and knowledge about hereditary cancer : European Reference Network on Genetic Tumour Risk Syndromes. FAMILIAL CANCER, 18(2), 281–284.
Chicago author-date
Vos, Janet R, Lisette Giepmans, Claas Röhl, Nicoline Geverink, Nicoline Hoogerbrugge, on behalf of ERN Genturis, Bruce Poppe, and Kathleen Claes. 2019. “Boosting Care and Knowledge About Hereditary Cancer : European Reference Network on Genetic Tumour Risk Syndromes.” Familial Cancer 18 (2): 281–284.
Chicago author-date (all authors)
Vos, Janet R, Lisette Giepmans, Claas Röhl, Nicoline Geverink, Nicoline Hoogerbrugge, on behalf of ERN Genturis, Bruce Poppe, and Kathleen Claes. 2019. “Boosting Care and Knowledge About Hereditary Cancer : European Reference Network on Genetic Tumour Risk Syndromes.” Familial Cancer 18 (2): 281–284.
Vancouver
1.
Vos JR, Giepmans L, Röhl C, Geverink N, Hoogerbrugge N, ERN Genturis on behalf of, et al. Boosting care and knowledge about hereditary cancer : European Reference Network on Genetic Tumour Risk Syndromes. FAMILIAL CANCER. 2019;18(2):281–4.
IEEE
[1]
J. R. Vos et al., “Boosting care and knowledge about hereditary cancer : European Reference Network on Genetic Tumour Risk Syndromes,” FAMILIAL CANCER, vol. 18, no. 2, pp. 281–284, 2019.
@article{8582474,
  abstract     = {Approximately 27-36million patients in Europe have one of the similar to 5.000-8.000 known rare diseases. These patients often do not receive the care they need or they have a substantial delay from diagnosis to treatment. In March 2017, twenty-four European Reference Networks (ERNs) were launched with the aim to improve the care for these patients through cross border healthcare, in a way that the medical knowledge and expertise travels across the borders, rather than the patients. It is expected that through the ERNs, European patients with a rare disease get access to expert care more often and more quickly, and that research and guideline development will be accelerated resulting in improved diagnostics and therapies. The ERN on Genetic Tumour Risk Syndromes (ERN GENTURIS) aims to improve the identification, genetic diagnostics, prevention of cancer, and treatment of European patients with a genetic predisposition for cancer. The ERN GENTURIS focuses on syndromes such as hereditary breast cancer, hereditary colorectal cancer and polyposis, neurofibromatosis and more rare syndromes e.g. PTEN Hamartoma Tumour Syndrome, Li Fraumeni Syndrome and hereditary diffuse gastric cancer.},
  author       = {Vos, Janet R and Giepmans, Lisette and Röhl, Claas and Geverink, Nicoline and Hoogerbrugge, Nicoline and ERN Genturis, on behalf of and Poppe, Bruce and Claes, Kathleen},
  issn         = {1389-9600},
  journal      = {FAMILIAL CANCER},
  keywords     = {Hereditary cancer,Cross border health care,European Reference Network,Rare diseases,Syndrome,Genetic,COLORECTAL-CANCER,PREVENTION,GUIDELINES},
  language     = {eng},
  number       = {2},
  pages        = {281--284},
  title        = {Boosting care and knowledge about hereditary cancer : European Reference Network on Genetic Tumour Risk Syndromes},
  url          = {http://dx.doi.org/10.1007/s10689-018-0110-6},
  volume       = {18},
  year         = {2019},
}

Altmetric
View in Altmetric
Web of Science
Times cited: